Table 7.

Logistic regression of risk factors for inactivated virus vaccine side effects reported by Algerian healthcare workers (n = 450).

Predictor	B (SE)	Wald	AOR	CI 95%	Sig.
Sex: female (vs. male)	0.916 (0.234)	15.288	2.500	1.579–3.959	< 0.001
Age group: 31–40 yo (vs. 20–30 yo)	0.601 (0.255)	5.552	1.823	1.106–3.004	0.018
Age group: 41–50 yo (vs. 20–30 yo)	0.231 (0.312)	0.551	1.260	0.684–2.323	0.458
Age group: 51–60 yo (vs. 20–30 yo)	– 0.028 (0.430)	0.004	0.972	0.418–2.261	0.948
Age group: > 60 yo (vs. 20–30 yo)	0.636 (0.930)	0.468	1.890	0.305–11.692	0.494
Tobacco: smoker (vs. non-smoker)	– 0.067 (0.356)	0.036	0.935	0.466–1.877	0.850
Allergy: yes (vs. no)	1.249 (0.268)	21.666	3.487	2.061–5.901	< 0.001
Non-communicable disease: yes (vs. no)	0.125 (0.309)	0.163	1.133	0.618–2.078	0.686
Medications: yes (vs. no)	– 0.158 (0.280)	0.316	0.854	0.493–1.480	0.574
Previous infection: yes (vs. no)	0.864 (0.216)	16.067	2.373	1.555–3.621	< 0.001
Number of doses: two (vs. one)	0.312 (0.260)	1.431	1.366	0.820–2.275	0.232

Bold values refer to the statisitically signifcant values which are below 0.05.